Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118499) titled 'Mechanistic study of Rho-Rock signaling in the establishment of early embryonic polarity' on Feb. 6.
Study Type: Observational study
Study Design:
Non randomized control
Primary Sponsor: The Third Affiliated Hospital of Guangzhou Medical University
Condition:
Blastocyst formation failure
Intervention:
ROCK inhibitor-treated group:none
Control:none
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-02-08
Target Sample Size: ROCK inhibitor-treated group:12;Control:8;RHO inhibitor-treated group:12;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/...